FORXIGA
DAPAGLIFLOZINE
Active substance
DAPAGLIFLOZINE
Laboratory
MAPHAR
What is this medicine?
FORXIGA contains DAPAGLIFLOZINE. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
DAPAGLIFLOZINE, COMPRIME PELLICULE, 5 MG, BOITE DE 28
Common uses
General use context: oral form, with use determined by the doctor or pharmacist according to the situation.
Laboratory
MAPHAR
Strength
5 MG
Form
COMPRIME PELLICULE
Presentation
BOITE DE 28
Commercial status
Non commercialisé / Sans Prix
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: Not available in the verified source